Aesthetic manufacturer mesoestetic invited practitioners to its headquarters in Barcelona, on October 14.
The exclusive event hosted 13 aesthetic practitioners for an educational event focusing on innovation, scientific development and the newly launched mesofiller nexha injectable range.
The day commenced with a welcome from mesoestetic UK commercial director, Steven Schofield, who provided an overview of the company’s portfolio, including skincare, devices and injectables. This was followed by chief operating officer of mesoestetic Carles Font, who guided delegates on a tour of the company’s headquarters. The visit provided insight into the entire manufacturing and production process – from formulation to final packaging – including a tour of the quality control room, preparation areas and the ‘cold room’ where raw materials are stored.
Following the tour, Lizzie Calvert, marketing manager for mesoestetic UK, delivered a presentation examining current trends influencing the aesthetic specialty. Drawing on data from consulting company Rare:, Calvert explored developments in regenerative medicine, alongside strategies for patient retention and acquisition. The session promoted open discussion, with practitioners exchanging insights and best practices for enhancing patient loyalty and sustainable clinic growth.
Next, Wendy Rogers, training manager at mesoestetic UK, introduced the PATH concept – designed to optimise patient care through profundity, action, time and homecare. The model aims to guide practitioners in tailoring individual treatment journeys by considering consultation insights, achievable timelines, budgets and homecare solutions to enhance clinical outcomes.
After lunch, Dr Alfredo Martínez, head of the biotechnology unit at headquarters, delivered a presentation outlining the scientific principles of the mesofiller nexha range. Dr Martínez explained that the formulation combines cross-linked hyaluronic acid with succinic acid, designed to provide both corrective and biostimulatory benefits. Schofield revealed that a second generation of the injectable line is in development, encouraging delegates to look out for future updates.
The event concluded with mesoestetic UK’s first live demonstration, performed by aesthetic practitioner Dr Andrea Miralbell. The session showcased the mesofiller nexha volume treating the nasolabial folds and mesofiller nexha lips for perioral rejuvenation, followed by mesotherapy incorporating vitamins, amino acids and peptides aimed at revitalising the skin.
The evening entailed a fine dining experience at Restaurante Feroz, providing attendees with the opportunity to reflect on a day centred around education, innovation and professional collaboration with the mesoestetic team.
Schofield commented, “We love to bring our practitioners to headquarters here in Barcelona. It gives us the space to show them how we develop from concept, and manufacture our products to the highest pharmaceutical standard. It was also a great opportunity to discuss the upcoming product pipeline and to provide a detailed explanation of the new Nexha range of dermal fillers, highlighting how they differ from standard hyaluronic acid fillers.”
Aesthetic nurse prescriber Michelle Mclean was amongst the visiting practitioners at HQ. Discussing the trip with Aesthetics, Mclean commented, “It was such an insightful and inspiring visit to the mesoestetic HQ. It was fascinating to gain a deeper understanding of their extensive product portfolio and see the meticulous pharmaceutical-grade manufacturing process first-hand. A truly valuable experience that reinforces the science behind their innovation.”
